Amrize (NYSE:AMRZ – Get Free Report) released its quarterly earnings results on Tuesday. The company reported $0.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.59 by $0.03, Zacks reports. The firm had revenue of $2.84 billion for the quarter, compared to analyst estimates of $2.95 billion. The firm’s revenue was down .4% on a year-over-year basis.
Amrize Stock Performance
Shares of AMRZ stock traded down $0.33 on Thursday, hitting $63.37. 1,386,032 shares of the stock traded hands, compared to its average volume of 3,465,120. The company’s fifty day moving average is $55.76 and its 200 day moving average is $52.30. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.45 and a quick ratio of 0.97. Amrize has a 1-year low of $44.12 and a 1-year high of $64.83. The company has a market capitalization of $35.05 billion and a PE ratio of 34.44.
Analysts Set New Price Targets
Several equities research analysts have commented on the company. Weiss Ratings upgraded Amrize from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, February 11th. Oppenheimer reissued an “outperform” rating and set a $70.00 target price on shares of Amrize in a research report on Thursday. Deutsche Bank Aktiengesellschaft set a $59.00 price target on shares of Amrize in a report on Monday, December 8th. Royal Bank Of Canada boosted their price objective on shares of Amrize from $60.00 to $61.00 and gave the stock a “sector perform” rating in a research note on Thursday. Finally, Stephens started coverage on shares of Amrize in a research note on Friday, November 14th. They issued an “overweight” rating and a $60.00 target price on the stock. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $62.54.
Key Headlines Impacting Amrize
Here are the key news stories impacting Amrize this week:
- Positive Sentiment: Management proposed a sizable shareholder-return package — a $1.0 billion buyback authorization plus a one-time special dividend and a proposed annual dividend — which supports near-term EPS accretion and signals confidence in cash generation. Quiver Quant: Amrize jumps 11% on Q4 results
- Positive Sentiment: Strong cash flow and lower leverage: 2025 operating cash flow and free cash flow were robust and year‑end net leverage fell to ~1.1x, giving the company capacity to fund buybacks/dividends while maintaining investment flexibility. Quiver Quant: Cash flow and leverage detail
- Positive Sentiment: Upbeat 2026 outlook: management guided to mid-single-digit revenue growth and stronger adjusted‑EBITDA growth (roughly +8%–11%), which frames 2026 as a margin/cash-flow improvement year. Yahoo Finance: Q4 Earnings Call Highlights
- Positive Sentiment: Strategic M&A: Amrize closed the acquisition of PB Materials, adding 26 operational sites and West Texas aggregates reserves — expands North American scale and long‑term supply capacity in a high-growth market. Business Wire: Amrize closes PB Materials acquisition
- Neutral Sentiment: Form 10‑K filed showing full‑year 2025 revenue of $11.8B and adjusted EBITDA ~ $3.0B — useful baseline data for investors but largely confirmatory. TipRanks: Form 10-K filing
- Neutral Sentiment: Q4 results were mixed: EPS beat modestly ($0.62 vs $0.59 est.) but revenue missed (about $2.84B vs $2.95B est.) and revenue was roughly flat year‑over‑year — beats on EPS and margin commentary offset by softer top-line. Yahoo Finance: Earnings Call Transcript
- Neutral Sentiment: Unusual options activity: a surge in call buying signals short‑term bullish positioning by traders, which can amplify intraday moves but is not fundamental by itself.
- Negative Sentiment: Some sell‑side caution: Jefferies issued a Hold, reflecting that while returns and cash flow are attractive, valuation/near‑term growth execution may not justify a buy rating for all investors. Globe and Mail: Jefferies Hold
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently modified their holdings of the business. Mercer Global Advisors Inc. ADV grew its stake in shares of Amrize by 197.5% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 15,944 shares of the company’s stock worth $862,000 after purchasing an additional 10,584 shares during the last quarter. Beacon Pointe Advisors LLC purchased a new position in Amrize in the fourth quarter valued at about $935,000. Mackenzie Financial Corp grew its stake in shares of Amrize by 26.6% in the 4th quarter. Mackenzie Financial Corp now owns 57,743 shares of the company’s stock valued at $3,169,000 after buying an additional 12,146 shares in the last quarter. XTX Topco Ltd grew its stake in shares of Amrize by 57.5% in the 4th quarter. XTX Topco Ltd now owns 58,715 shares of the company’s stock valued at $3,175,000 after buying an additional 21,442 shares in the last quarter. Finally, Zimmer Partners LP lifted its stake in Amrize by 12.6% in the fourth quarter. Zimmer Partners LP now owns 366,000 shares of the company’s stock valued at $19,793,000 after acquiring an additional 41,000 shares during the last quarter.
About Amrize
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Recommended Stories
- Five stocks we like better than Amrize
- Your Bank Account Is No Longer Safe
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
